Clément TRAN

En résumé

Entreprises

• Sanofi Pasteur MSD - Head of planning & project mngt

  Paris 2015 - maintenant Reporting to VP Development, my mission is to:
  - Implement PPM best practices, metrics/dashboards and develop strong collaboration relationship across Development organization
  - Manage Dev functions activities portfolio & projects portfolio, implement tool to provide visibility and facilitate decision making at function/project and Executive levels
  - Plan and execute department-wide projects that align with business priorities
  

• Sanofi Pasteur MSD - Head of Clinical Operations

  Paris 2013 - 2015 My mission is to oversee the clinical trials execution in order to deliver clinical data with the best Quality/Cost/Time balance.
  I achieve my mission by
  - leading and developing the clinical operations staff (Clinical Trial Managers and Clinical Trial Assistants)
  - providing strategic direction for out-sourcing
  - developing and implementing processes and systems related to operational activities.

• Sanofi Pasteur MSD - Senior Clinical Projects Leader

  Paris 2010 - 2013 Fully accountable for Timelines, Quality and Cost of International vaccines clinical trials.
  Covered countries: Belgium, Canada, Denmark, Finland, France, Germany, Italy, Spain, Sweden, and UK.
  
  Acting as a Project Leader in a matrix organisation, I am in charge of:
  
  ▫ Development of Protocol, Project sizing and Planning,
  ▫ Supervision of study documents development such as Informed Consent Form, Case Report Form, Diary Card, Study Specific Procedures and Guidelines,
  ▫ Regulatory submissions and contracts negotiation,
  ▫ CROs selection and study budget forecast and management (ranging from 1.5 to 5 million € per study),
  ▫ Country affiliates and shareholders liaison, supervision of investigational sites selection,
  ▫ Organisation and Chair of Investigators Meetings, participation to CRA training.

• Sanofi Pasteur MSD - Clinical Projects Coordinator

  Paris 2005 - 2010 Project coordination in a matrix organisation:
  
  ▫ Development of study documents,
  ▫ Project Planning,
  ▫ Development of Study Specific Procedures and Guidelines,
  ▫ Regulatory submissions preparation,
  ▫ CROs selection and study budget monitoring,
  ▫ Investigational sites selection,
  ▫ Participation to CRA training and Investigators Meetings.

• Sanofi Pasteur MSD - Central CRA

  Paris 2003 - 2005 ▫ Global coordination of activities related to monitoring and management of monitoring CRO.
  ▫ Development of study documents

• Pharmascan - CRA

  2000 - 2003 Phase I to IV clinical trials monitoring and coordination:
  ▫ Several therapeutic areas such as dermatology, gynaecology, ophthalmology, paediatric,
  ▫ Different medical structures such as hospital, clinical investigation centre (CIC) and private practices

Formations

• DIU FARC (Paris)

  Paris 1999 - 2000

Réseau

• Huit HUIT